{"Title": ["BUZZ-U.S. STOCKS ON THE MOVE-Obalon Therapeutics, Jabil Inc, Cinedigm Corp", "BUZZ-U.S. STOCKS ON THE MOVE-Penn National Gaming, Ovid Therapeutics, Ampio Pharma", "BUZZ-U.S. STOCKS ON THE MOVE-LightInTheBox, Carmax, Slack Technologies, Workhorse Group", "Acasti Pharma: FDA Requires Pivotal Efficacy Analyses For TRILOGY 2", "BUZZ-U.S. STOCKS ON THE MOVE-Dynavax Technologies, Home Depot, PBF Energy", "Amarin Stock Looks Like a Heart-Healthy Buy on the Dip", "Look Anywhere but Acasti Pharma Stock for Opportunity", "Confounding Decline Creates an Opportunity in Amarin Stock", "BUZZ-U.S. STOCKS ON THE MOVE-Obalon Therapeutics, Jabil Inc, Cinedigm Corp", "First-Mover Advantage Will Benefit Amarin Stock More Than You Think", "Why Amarin Stock Is Getting No Love Early in 2020", "Risks Remain, but Amarin Stock Is a Buy at Today\u2019s Prices", "3 Beaten-Down Biotech Stocks With +50% Upside Potential", "ACST Plunges On Data Delay, MREO On Watch, AQST Faces FDA In Sep.", "Consider Adding Amarin to Your Portfolio as Its Competition Falters", "Acasti Pharma Stock Has One Last Chance", "Acasti Pharma Is a Risky Play After Releasing Disappointing Data", "Amarin Stock Projections Are Based on Hype and Hope", "Amarin Stock is Still Fully Valued Despite All the Good News", "Why Amarin Stock Is Poised for a Healthy 2020", "After FDA Approval, Amarin Stock Is Stuck in Worrisome Trading", "Acasti Pharma Stock Could Soar Above $3 Soon", "Acasti: CaPre Trial Fails To Meet Endpoint On Unusually Large Placebo Effect", "All Bets Are Off for Amarin Stock", "Amarin Stock Will Deliver More Upside for Patient Investors", "Amarin Stock Projections Are Based on Hype and Hope", "Health Care Sector Update for 12/24/2019: LCTX,ACST,ACST.V,MBOT", "ACST On Watch, ITCI Jumps 250% On Trial Data, CVM Slumps, FDA Nod For AGN", "Amarin Stock is at Sky-High Levels Already Assumes All the Good News", "Will These Pharma Stocks Soar Or Swoon This Month? (ACER, ACST, ADMS, SLGL)", "Amarin Stock Has Lower Risk, But How Much Reward?", "Amarin Stock Has Lower Risk, But How Much Reward?", "3 Healthcare Stocks With Big Catalysts in January", "6 Top Gainers In Healthcare Sector (NBY, PIRS, VRCA...)", "6 Top Gainers In Healthcare Sector (GHDX, THC, IART\u2026)", "5 Top Gainers In Healthcare Sector (LCI, SOLY, EVOK...)", "5 Top Gainers In Healthcare Sector (OTLK, NEPT, EOLS...)", "Health Care Sector Update for 06/26/2019: ACST, ABBV, EYEG, NBRV, AGN, JNJ, PFE, ABT, MRK, AMGN", "Health Care Sector Update for 04/01/2019: BHC,BHC.TO,ACST,ACST.V,ZIOP,MNKD,UTHR,GSK", "Health Care Sector Update for 04/01/2019: ACST,ZIOP,MNKD,UTHR", "5 Healthcare Stocks Facing Key Catalysts In Q4, 2019", "Health Care Sector Update for 04/01/2019: ACST,ZIOP,MNKD,UTHR", "Health Care Sector Update for 01/09/2019: ARQL, NEO, EGL, SAIC, ACST, JNJ, PFE, ABT, MRK, AMGN", "Health Care Sector Update for 12/31/2018: HLTH,ACST,ACST.V,ADMP,MBOT", "Health Care Sector Update for 12/31/2018: ACST,ADMP,MBOT", "Generic Industry on Path to Recovery: 3 Hot Picks for 2019", "Pre-Market Earnings Report for November 14, 2018 : M, GOOS, MTOR, QIWI, ECC, ALDX, TST, APRN, EAST, ACST, XELB, SPCB", "Health Care Sector Update for 10/11/2018: ACST,ACST.V,TRXC,CRSP,BOLD", "Health Care Sector Update for 04/01/2019: BHC,BHC.TO,ACST,ACST.V,ZIOP,MNKD,UTHR,GSK", "Health Care Sector Update for 10/04/2018: MNK,PX,ACST,ACST.V,ALNY,TLR", "Health Care Sector Update for 10/04/2018: ACST,ALNY,TLRY", "Mid-Afternoon Market Update: Stitch Fix Falls After Q4 Results; Pyxus International Shares Climb", "Health Care Sector Update for 12/28/2017: VTVT,CBMG,ACST,ACST.V", "Health Care Sector Update for 12/28/2017: ACST,ACST.V,CBMG,SUPN", "Health Care Sector Update for 12/21/2017: MBRX,AEZS,ACST,ACST.V", "Health Care Sector Update for 12/21/2017: JAZZ,AEZS,JNJ,ACST,ACST.V", "Health Care Sector Update for 10/04/2018: ACST,ACST.V,ALNY,TLRY", "Health Care Sector Update for 11/20/2017: ACOR,ACST,ACST.V,ANTH", "Health Care Sector Update for 10/26/2016: ACST", "Health Care Sector Update for 09/14/2016: ACST,VTAE,AGN,APPY", "Health Care Sector Update for 01/08/2016: MNTA, MYL, NEPT, GIL", "Health Care Sector Update for 01/08/2016: ATHX,NEPT,GI", "Tuesday Sector Laggards: Diagnostics, Education & Training Services", "Mallinckrodt Beats on Q3 Earnings and Revenues, Ups View - Analyst Blog", "Health Care Sector Update for 11/20/2017: SMMT,ACST,ACST.V,ANTH", "Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape", "Acasti Pharma (ACST) Soars: Stock Adds 10.0% in Session - Tale of the Tape", "Wednesday Sector Leaders: General Contractors & Builders, Diagnostics", "Healthcare Stocks Falling; Neptune Tech, Subsidiary Settle Patent Fight with Aker BioMarine Over Krill Oil Technology", "Sector Update: Healthcare", "Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape"], "Elapsed Time": ["6 DAYS AGO", "6 DAYS AGO", "6 DAYS AGO", "6 DAYS AGO", "MAY 19, 2020", "MAR 6, 2020", "FEB 28, 2020", "FEB 28, 2020", "6 DAYS AGO", "FEB 24, 2020", "FEB 19, 2020", "FEB 14, 2020", "FEB 11, 2020", "FEB 10, 2020", "FEB 4, 2020", "JAN 29, 2020", "FEB 26, 2020", "JAN 27, 2020", "JAN 27, 2020", "JAN 17, 2020", "JAN 16, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 10, 2020", "JAN 28, 2020", "JAN 27, 2020", "DEC 24, 2019", "DEC 23, 2019", "DEC 20, 2019", "DEC 15, 2019", "DEC 11, 2019", "DEC 11, 2019", "JAN 9, 2020", "JUL 29, 2019", "JUL 24, 2019", "JUL 22, 2019", "JUL 18, 2019", "JUN 26, 2019", "APR 1, 2019", "APR 1, 2019", "OCT 7, 2019", "APR 1, 2019", "JAN 9, 2019", "DEC 31, 2018", "DEC 31, 2018", "DEC 28, 2018", "NOV 13, 2018", "OCT 11, 2018", "APR 1, 2019", "OCT 4, 2018", "OCT 4, 2018", "OCT 2, 2018", "DEC 28, 2017", "DEC 28, 2017", "DEC 21, 2017", "DEC 21, 2017", "OCT 4, 2018", "NOV 20, 2017", "OCT 26, 2016", "SEP 14, 2016", "JAN 8, 2016", "JAN 8, 2016", "OCT 14, 2014", "AUG 13, 2014", "NOV 20, 2017", "JUL 10, 2014", "JUN 16, 2014", "MAR 19, 2014", "DEC 17, 2013", "DEC 17, 2013", "JUL 24, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-obalon-therapeutics-jabil-inc-cinedigm-corp-2020-06-19", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-penn-national-gaming-ovid-therapeutics-ampio-pharma-2020-06", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-lightinthebox-carmax-slack-technologies-workhorse-group-2020", "https://www.nasdaq.com/articles/acasti-pharma%3A-fda-requires-pivotal-efficacy-analyses-for-trilogy-2-2020-06-19", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-dynavax-technologies-home-depot-pbf-energy-2020-05-19", "https://www.nasdaq.com/articles/amarin-stock-looks-like-a-heart-healthy-buy-on-the-dip-2020-03-06", "https://www.nasdaq.com/articles/look-anywhere-but-acasti-pharma-stock-for-opportunity-2020-02-28", "https://www.nasdaq.com/articles/confounding-decline-creates-an-opportunity-in-amarin-stock-2020-02-28", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-obalon-therapeutics-jabil-inc-cinedigm-corp-2020-06-19", "https://www.nasdaq.com/articles/first-mover-advantage-will-benefit-amarin-stock-more-than-you-think-2020-02-24", "https://www.nasdaq.com/articles/why-amarin-stock-is-getting-no-love-early-in-2020-2020-02-19", "https://www.nasdaq.com/articles/risks-remain-but-amarin-stock-is-a-buy-at-todays-prices-2020-02-14", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-with-50-upside-potential-2020-02-11", "https://www.nasdaq.com/articles/acst-plunges-on-data-delay-mreo-on-watch-aqst-faces-fda-in-sep.-2020-02-10", "https://www.nasdaq.com/articles/consider-adding-amarin-to-your-portfolio-as-its-competition-falters-2020-02-04", "https://www.nasdaq.com/articles/acasti-pharma-stock-has-one-last-chance-2020-01-29", "https://www.nasdaq.com/articles/acasti-pharma-is-a-risky-play-after-releasing-disappointing-data-2020-02-26", "https://www.nasdaq.com/articles/amarin-stock-projections-are-based-on-hype-and-hope-2020-01-27", "https://www.nasdaq.com/articles/amarin-stock-is-still-fully-valued-despite-all-the-good-news-2020-01-27", "https://www.nasdaq.com/articles/why-amarin-stock-is-poised-for-a-healthy-2020-2020-01-17", "https://www.nasdaq.com/articles/after-fda-approval-amarin-stock-is-stuck-in-worrisome-trading-2020-01-16", "https://www.nasdaq.com/articles/acasti-pharma-stock-could-soar-above-%243-soon-2020-01-13", "https://www.nasdaq.com/articles/acasti%3A-capre-trial-fails-to-meet-endpoint-on-unusually-large-placebo-effect-2020-01-13", "https://www.nasdaq.com/articles/all-bets-are-off-for-amarin-stock-2020-01-10", "https://www.nasdaq.com/articles/amarin-stock-will-deliver-more-upside-for-patient-investors-2020-01-28", "https://www.nasdaq.com/articles/the-success-of-vascepa-actually-might-be-a-problem-for-amarin-2019-12-30", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-24-2019%3A-lctxacstacst.vmbot-2019-12-24", "https://www.nasdaq.com/articles/acst-on-watch-itci-jumps-250-on-trial-data-cvm-slumps-fda-nod-for-agn-2019-12-23", "https://www.nasdaq.com/articles/amarin-stock-is-at-sky-high-levels-already-assumes-all-the-good-news-2019-12-20", "https://www.nasdaq.com/articles/will-these-pharma-stocks-soar-or-swoon-this-month-acer-acst-adms-slgl-2019-12-15", "https://www.nasdaq.com/articles/amarin-stock-has-lower-risk-but-how-much-reward-2019-12-11-0", "https://www.nasdaq.com/articles/amarin-stock-has-lower-risk-but-how-much-reward-2019-12-11", "https://www.nasdaq.com/articles/3-healthcare-stocks-with-big-catalysts-in-january-2020-01-09", "https://www.nasdaq.com/articles/6-top-gainers-in-healthcare-sector-nby-pirs-vrca...-2019-07-29", "https://www.nasdaq.com/articles/6-top-gainers-in-healthcare-sector-ghdx-thc-iart...-2019-07-24", "https://www.nasdaq.com/articles/5-top-gainers-in-healthcare-sector-lci-soly-evok...-2019-07-22", "https://www.nasdaq.com/articles/5-top-gainers-in-healthcare-sector-otlk-nept-eols...-2019-07-18", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-26-2019%3A-acst-abbv-eyeg-nbrv-agn-jnj-pfe-abt-mrk-amgn", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-01-2019%3A-bhcbhc.toacstacst.vziopmnkduthrgsk-2019-04-01", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-01-2019%3A-acstziopmnkduthr-2019-04-01", "https://www.nasdaq.com/articles/5-healthcare-stocks-facing-key-catalysts-in-q4-2019-2019-10-07", "https://www.nasdaq.com/articles/health-care-sector-update-04012019-acstziopmnkduthr-2019-04-01-0", "https://www.nasdaq.com/articles/health-care-sector-update-01092019-arql-neo-egl-saic-acst-jnj-pfe-abt-mrk-amgn-2019-01-09", "https://www.nasdaq.com/articles/health-care-sector-update-12312018-hlthacstacstvadmpmbot-2018-12-31", "https://www.nasdaq.com/articles/health-care-sector-update-12312018-acstadmpmbot-2018-12-31", "https://www.nasdaq.com/articles/generic-industry-on-path-to-recovery%3A-3-hot-picks-for-2019-2018-12-28", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-14-2018-m-goos-mtor-qiwi-ecc-aldx-tst-aprn-east-acst", "https://www.nasdaq.com/articles/health-care-sector-update-10112018-acstacstvtrxccrspbold-2018-10-11", "https://www.nasdaq.com/articles/health-care-sector-update-04012019-bhcbhctoacstacstvziopmnkduthrgsk-2019-04-01-0", "https://www.nasdaq.com/articles/health-care-sector-update-10042018-mnkpxacstacstvalnytlr-2018-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-10042018-acstalnytlry-2018-10-04", "https://www.nasdaq.com/articles/mid-afternoon-market-update-stitch-fix-falls-after-q4-results-pyxus-international-shares", "https://www.nasdaq.com/articles/health-care-sector-update-12282017-vtvtcbmgacstacstv-2017-12-28", "https://www.nasdaq.com/articles/health-care-sector-update-12282017-acstacstvcbmgsupn-2017-12-28", "https://www.nasdaq.com/articles/health-care-sector-update-12212017-mbrxaezsacstacstv-2017-12-21", "https://www.nasdaq.com/articles/health-care-sector-update-12212017-jazzaezsjnjacstacstv-2017-12-21", "https://www.nasdaq.com/articles/health-care-sector-update-10042018-acstacstvalnytlry-2018-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-11202017-acoracstacstvanth-2017-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-10262016-acst-2016-10-26", "https://www.nasdaq.com/articles/health-care-sector-update-09142016-acstvtaeagnappy-2016-09-14", "https://www.nasdaq.com/articles/health-care-sector-update-01082016-mnta-myl-nept-gil-2016-01-08", "https://www.nasdaq.com/articles/health-care-sector-update-01082016-athxneptgi-2016-01-08", "https://www.nasdaq.com/articles/tuesday-sector-laggards-diagnostics-education-training-services-2014-10-14", "https://www.nasdaq.com/articles/mallinckrodt-beats-on-q3-earnings-and-revenues-ups-view-analyst-blog-2014-08-13", "https://www.nasdaq.com/articles/health-care-sector-update-11202017-smmtacstacstvanth-2017-11-20", "https://www.nasdaq.com/articles/acasti-pharma-inc.-acst-jumps%3A-stock-rises-7.6-tale-of-the-tape-2014-07-10", "https://www.nasdaq.com/articles/acasti-pharma-acst-soars%3A-stock-adds-10.0-in-session-tale-of-the-tape-2014-06-16", "https://www.nasdaq.com/articles/wednesday-sector-leaders-general-contractors-builders-diagnostics-2014-03-19", "https://www.nasdaq.com/articles/healthcare-stocks-falling-neptune-tech-subsidiary-settle-patent-fight-aker-biomarine-over", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-17-0", "https://www.nasdaq.com/articles/acasti-pharma-acst-jumps%3A-stock-moves-7.3-higher-tale-of-the-tape-2014-07-24"], "Content": []}